ImmunTraCkeR ® as a reliable TCR repertoire profiling tool to understand immune response and to explore immunotherapy biomarkers

Meeting abstracts Over the last decade, the host immunity has emerged as a critical determinant of cancer development and of response to therapy. Great progress has been made in the development of immunotherapies, which leverage the patient’s immune system to reach better clinical outcomes.